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Introduction
The regeneration potential of normal bone is excellent 
due to extensive vascular supply. However, healing of 
large bone defects after severe trauma, reconstructive 
or ablative surgery is still challenging despite recent 
advances in technical and surgical methods.1 Over the 
past decades, bone grafts and different biomaterials have 
been employed with variable results.1 Therefore, there is 
still a need to enhance fracture or bone defect repair. 
Autologous bone grafts are still considered the gold 
standard for reconstructive bone surgery due to low 
immunogenicity, simultaneous presence of stem cells, 
and growth factors as well as their osteoinductive/osteo-
conductive properties. However, donor site morbidity 
and limited availability are of concern.1
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Therefore, suitability of bone tissue engineering and 
cell-based therapies utilizing stem cells, co-incubated with 
biological factors, and seeded on biomaterials have recently 
been explored to regenerate bone.2 We and others have 
treated successfully patients with bone defects in cranio-
maxillofacial area using autologous human adipose stem 
cells (hASCs) in combination with biomaterials.3,4 Among 
the stem cells used, hASCs have gained popularity as alter-
native source of mesenchymal stem cells (MSCs) to human 
bone marrow stromal cells (hBMSCs) due to abundant 
availability, ease of harvesting, simple processing, and 
proven ability to differentiate into multiple lineages includ-
ing osteoblasts.5
Human ASCs are traditionally cultured and expanded 
in medium supplemented with animal-derived fetal 
bovine serum (FBS) posing the risk for zoonotic diseases 
and allergic reactions. Hence, the use of FBS is one con-
cern for its direct clinical application in humans.6 
Therefore, standardized human serum (HS) has recently 
being investigated, and research is directed toward the 
development of even xeno-free culture media, produced 
according to good manufacturing practice.7,8 It is also 
possible to use autologous HS for cell expansion.3,4 
Isolated hASCs have also co-incubated with osteogenic 
nutrients to promote osteogenic differentiation in vitro 
and, finally to stimulate new bone formation in vivo.3 
Among the additives, the osteogenic potential of bone 
morphogenetic protein-2 and -7 (BMP-2 and BMP-7) on 
hASCs has been investigated over the last years.9 
Currently, the osteoinductive growth factors BMP-2 and 
BMP-7 are in clinical use.3,10,11 However, controversial 
results were recently reported regarding their beneficial 
role in osteogenesis requiring further clarification.11
Implanted biomaterials serve as initial scaffolds, cell 
attachment bases and may induce signals for cell differen-
tiation, and in the past, several bioactive materials were 
thoroughly investigated.12 Among those, bioactive glass 
(BAG) and beta-tricalcium phosphate (β-TCP) have been 
used widely in oral–maxillofacial and orthopedic surgery 
due to good biocompatibility and ability to support osteo-
blastic growth and maturation.13–15 Customized implants 
that contain osteogenic cells (e.g. hASCs), osteoinductive 
factors (e.g. BMPs) along with a synthetic osteoconductive 
matrix (e.g. BAG or β-TCP) represent an attractive alterna-
tive to autografts and allografts while uniting all three 
bone-forming properties in a more controlled and effective 
combination.
To our knowledge, the response of hASCs to BMP-
2/7 and BAG or β-TCP after expansion in HS has not 
been reported yet. Therefore, the aim of the current study 
was to evaluate and compare the effect of (1) BAG and 
β-TCP and (2) BMP-2 and BMP-7 or both on osteogenic 
differentiation of hASCs when maintained in medium 
containing HS.
Materials and methods
Ethics statement, hASCs isolation, and culture
The study was conducted in accordance with the Ethics 
Committee of the Pirkanmaa Hospital District, Tampere, 
Finland (R03058), and the Declaration of Helsinki 1975, 
revised Hong Kong 1989. Adipose tissue samples were 
harvested as by-products of open surgical procedures 
from six patients (age = 39 ± 18 years, one male and five 
female patients) at the Tampere University Hospital, 
Finland. A written consent form was obtained from each 
patient before the procedure. Subsequently, hASCs were 
isolated and cultured as described elsewhere.5 Briefly, 
samples were washed with Dulbecco’s phosphate-buffered 
saline (DPBS) (Invitrogen, UK), minced manually into 
smaller pieces, digested with 1.5 mg/mL collagenase type 
I (Life Technologies, UK) and were incubated in a water 
bath at 37°C for 90 min. Subsequently, the digested tissue 
was centrifuged (600g, 10 min) in consecutive steps 
achieving sufficient segregation of hASCs from connec-
tive tissue. The supernatant was discarded, the cell pellet 
resuspended in 10% HS and, finally, filtered through a 
100 µm strainer. Subsequently, isolated cells were main-
tained and expanded in polystyrene flasks (Nunc, 
Denmark) in control medium (CM) containing Dulbecco’s 
modified Eagle medium (DMEM)/Ham’s nutrient mix-
ture F-12 (F-12 1:1; Invitrogen) that was supplemented 
with 1% L-glutamine (GlutaMAX; Invitrogen), 1% antibi-
otics (100 U/mL penicillin, 0.1 mg/mL streptomycin; 
Invitrogen), and 10% HS (PAA Laboratories GmbH, 
Austria) at 37°C and 5% CO2. The cells were passaged 
when the flasks approached about 80% confluency and 
were detached enzymatically using trypsin (TrypLE 
Select™, Invitrogen). Finally, expanded hASCs were cry-
opreserved using liquid nitrogen in a freezing solution 
containing 10% dimethyl sulfoxide (Hybri-Max, Sigma–
Aldrich, USA) and 10% HS. Before experiments, hASCs 
were thawed and expanded in CM, and cell passages 1–4 
were used.
Flow cytometric analysis of hASC surface 
marker expression
After primary culture for cell passages 1–2, hASCs were 
harvested and characterized by flow cytometry (FACSAria™; 
BD Biosciences, Belgium) as described previously.16 
Monoclonal antibodies against CD14–phycoerythrin–
cyanine (PECy7), CD19–PECy7, CD90–allophycocyanin 
(APC) (BD Biosciences), CD34–APC, HLA-DR–
phycoerythrin (PE) (ImmunoTools GmbH, Germany), and 
CD105–PE (R&D Systems Inc., USA) were employed. 
Analysis was performed on 10,000 cells per sample, and 
unstained cell samples were used to compensate for the 
background autofluorescence levels.
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Biomaterials and growth factors
Commercially available biomaterials accepted for clinical 
use were selected for the study. BAG granules (S53P4, 23% 
Na2O, 20% CaO, 53% SiO2, 4% P2O5, BoneAlive granules, 
1.0–2.0 mm; BoneAlive Biomaterials Ltd, Finland) and β-
TCP granules (ChronOS granules, 1.4–2.8 mm, porosity 
60%; Synthes, Switzerland) were used in the study. Also, 
clinically used BMP-2 and BMP-7 (Sigma–Aldrich) were 
chosen as additive for the osteogenic media evaluated.
Seeding and osteogenic differentiation of 
hASCs on biomaterial combinations
Sterile BAG and β-TCP granules (400 µL biomaterials/
well) were incubated with CM in a 24-well plate (Nunc) 
for 48 h before cell seeding for equilibration purposes. For 
osteogenic medium (OM), CM was supplemented with 
L-ascorbic acid-2-phosphate (50 mM), β-glycerophosphate 
(500 µM), and dexamethasone (10 µM) (all Sigma–
Aldrich). Subsequently, individual treatment media (TM) 
were produced containing OM only, OM + BMP-2 
(Sigma–Aldrich, dose 100 ng/mL), OM + BMP-7 (Sigma–
Aldrich, dose 100 ng/mL), and OM + BMP-2 + BMP-7 
(both 100 ng/mL) resulting in the following combinations: 
(1) BAG + CM (BAG + CM), (2) BAG + OM (BAG + 
OM), (3) BAG + OM + BMP-2 (BAG + BMP-2), (4) BAG 
+ OM + BMP-7 (BAG + OM + BMP-7), (5) BAG + OM 
+ BMP-2/7 (BAG + BMP-2/7), (6) β-TCP + CM (TCP + 
CM), (7) β-TCP + OM (TCP + OM), (8) β-TCP + OM + 
BMP-2 (TCP + BMP-2), (9) β-TCP + OM + BMP-7 (TCP 
+ BMP-7), and (10) β-TCP + OM + BMP-2/7 (TCP + 
BMP-2/7) (Table 1). Dosages for BMPs were chosen 
based on earlier studies.17 Previously isolated hASCs were 
suspended with each individual treatment medium to initi-
ate osteogenic differentiation and, finally, were seeded on 
both biomaterials (50,000 cells/well) as described ear-
lier.17 Seeded grafts were maintained in culture at 37.5°C 
and 5% CO2 changing individual media every 48 h until 
final analyses.
Cell amount
After 1, 7, and 14 days in culture, the amount of hASCs 
was evaluated quantitatively using CyQUANT®, Cell 
Proliferation Assay Kit (Molecular Probes, Invitrogen) 
that measured DNA amounts in samples as described else-
where.8 Briefly, all cells were lysed using 0.1% Triton-X 
100 buffer (Sigma–Aldrich), and the supernatant was col-
lected and stored at −80°C until final analyses. A volume 
of 20 µL of each sample were mixed with CyQUANT GR 
dye and lysis buffer in a 96-well plate (Nunc) after a 
freeze–thaw cycle. Fluorescence signals were measured 
with a multiple plate reader (Victor 1420 Multilabel 
Counter; Wallac, Finland) at 480 or 520 nm.
Alkaline phosphatase staining and 
quantitative alkaline phosphatase analyses
The osteogenic differentiation of isolated hASCs was 
determined qualitatively by alkaline phosphatase (ALP) 
staining and quantitatively by ALP measurements. 
Subsequently, after 1, 7, and 14 days in culture, all samples 
were stained using a leukocyte ALP kit (Sigma–Aldrich, 
#86R-1KT). Therefore, cell cultures were washed twice 
using DPBS and fixed in 4% paraformaldehyde. ALP stain-
ing solution was pipetted into each well, incubated for 15 
min, washed in deionized water, and finally evaluated 
macroscopically.
After 1, 7, and 14 days in culture, quantitative alkaline 
phosphatase (qALP) activities were measured photometri-
cally according to Sigma ALP (Sigma–Aldrich) at 405 nm 
(Victor 1420). The ALP activities were measured from the 
same Triton-X 100 lysates as used for the cell numbers.
Quantitative real-time reverse transcription 
polymerase chain reaction to measure early 
markers of osteogenic differentiation
The mRNA expression levels of early markers in osteo-
genesis including osteopontin (OPN), runt-related 
Table 1. Overview on experimental design—group assignments
BAGa + CMb BAG + OMc BAG + BMP-2d BAG + BMP-7e BAG + BMP-2/7f
TCPg + CM TCP + OM TCP + BMP-2 TCP + BMP-7 TCP + BMP-2/7
BAG: bioactive glass; CM: control medium; OM: osteogenic medium; BMP: bone morphogenetic protein; TCP: tricalcium phosphate; E-TCP:  
beta-tricalcium phosphate.
aBioactive glass granules (BAG group).
bControl medium.
cOsteogenic medium.
dBone morphogenic protein 2 (BMP-2 medium).
eBone morphogenic protein 7 (BMP-7 medium).
fCombination of bone morphogenic protein 2 and 7 (BMP-2/7 medium).
gBeta-tricalcium phosphate granules (E-TCP group).
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transcription factor 2 (RUNX-2), collagen type-1 (Col-1), 
and osteocalcin (OC) were measured 14 days after cell 
seeding and incubation using quantitative real-time 
reverse transcription polymerase chain reaction (qRT-
PCR). The expression of RPLP0 was used to normalize 
expression levels between samples. Therefore, total RNA 
was isolated from hASCs using TRIzol reagent 
(Invitrogen) following the manufacturer’s guidelines. 
Sequences and accession numbers of all primers (Oligomer 
Oy, Finland) are displayed in Table 2. All reactions were 
performed using ABI Prism 7300 Sequence Detection 
Systems (Applied Biosystems, UK), and the relative gene 
expression for each individual marker was calculated 
according to a mathematical model.
Expression of vascular endothelial growth factor
At days 1, 7, and 14, vascular endothelial growth factor 
(VEGF) was measured using a human VEGF immunoassay 
(R&D Systems, UK) according to the manufacturer’s 
instructions. Briefly, 50 µL of assay diluent and 200 µL cell 
culture sample supernate were added into each well and 
incubated for 2 h at room temperature (RT). Subsequently, 
all samples were aspirated and washed for three times 
before 200 µL of VEGF conjugate was pipetted into each 
well and incubated for 2 h at RT. The previous aspiration-
washing cycle was repeated followed by addition of 200 µL 
substrate solution and incubated for 20 min at RT. Finally, 
the reaction was terminated with 50 µL of stop solution, 
and optical density of each well was determined using a 
microplate reader set at a wave length of 450 nm.
Statistical analyses
Quantitative analyses of cell amounts and qALP were run 
in duplicates per experiment, and experiments were 
repeated five times. Quantitative measurements of OPN, 
RUNX-2, Col-1, OC, and VEGF were run in duplicates per 
experiment, and experiments were repeated three times. All 
data were presented as mean ± standard deviation (SD). A 
one-way analysis of variance with the Bonferroni post hoc 
test for multiple comparisons was used to study statistically 
significant differences between study groups. The nonpara-
metric Spearman correlation test was used to study correla-
tion between DNA amounts, expression of VEGF, and ALP 
activity. Values of p < 0.05 were regarded as significant. All 
graphs and statistics were done using GraphPad Prism 5.01 
software.
Results
Cell surface maker profile of hASC in 
medium containing 10% HS
Human ASCs were isolated and expanded using cell cul-
ture medium containing 10% HS. After expansion, cell 
surface marker expression profile of hASCs was ana-
lyzed by flow cytometry. Human ASCs showed positive 
expression (>70%) for the surface markers CD73 (Ecto-
5′-nucleotidase), CD90 (Thy-1), and CD105 (Endoglin) 
and lacked (<2%) the expression of CD14, CD19, and 
HLA-DR. Furthermore, moderate expression was 
recorded for the hematopoietic progenitor marker CD34. 
Cytometric analyses confirmed the characteristic immu-
nophenotype of hASCs, which was similar to earlier 
reports.16
Cell amounts in BAG were greater than in 
E-TCP in OM and CM
Quantitatively, the DNA amount was analyzed as an indi-
cator of cell amounts at days 1, 7, and 14. Results of both 
Table 2. Overview on sequences of osteogenic marker genes determined
Name Primer direction Sequences Product size (bp)
hRPLP0a Forward 5c-AAT CTC CAG GGG CAC CAT T-3c 70
 Reverse 5c-CGC TGG CTC CCA CTT TGT-3c  
hCOL1b Forward 5c-CCA GAA GAA CTG GTA CAT CAG CAA-3c 94
 Reverse 5c-CGC CAT ACT CGA ACT GGA ATC-3c  
hOCc Forward 5c-AGC AAA GGT GCA GCC TTT GT-3c 94
 Reverse 5c-GCG CCT GGG TCT CTT CAC T-3c  
hOPNd Forward 5c-GCC GAC CAA GGA AAA CTC ACT-3c 71
 Reverse 5c-GGC ACA GGT GAT GCC TAG GA-3c  
hRUNX2e Forward CCCGTGGCCTTCAAGGT 76
 Reverse CGTTACCCGCCATGACAGTA  
aRibosomal protein, large, P0 (Acc.No.: NM_001002).
bCollagen, type I, alpha 1 (Acc.No.: NM_00088).
cOsteocalcin (Acc.No.: NM_000711).
dOsteopontin (Acc.No.: J04765).
eRunt-related transcription factor 2 (Acc.No.: NM_004348).
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Figure 1. Comparative overview on cell amount over time (N = 10 replicates per time point). Overall, cell amount increased 
continuously over time independent on biomaterial evaluated. Cell amount was greatest after exposure to BAG in OM. After 7 days, 
BAG increased cell amount significantly more in CM as compared to E-TCP. Generally, BMP supplementation decreased cell amount 
independent on biomaterial.
BAG: bioactive glass; E-TCP: beta-tricalcium phosphate; CM: control medium; OM: osteogenic medium; BMP: bone morphogenetic protein; TM: treat-
ment media.
The symbol “*” indicates significant difference between days 1–7 and days 7–14; “a” indicates significant difference between days 1 and 14; “b” 
indicates significant difference as compared to CM; “c” indicates significant difference as compared to OM; arrows represent significant differences 
between biomaterials.
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biomaterials, when maintained under the same culture 
conditions, were compared to each other. In the BAG 
group, cell number increased continuously and signifi-
cantly in CM and TM (p < 0.0001). In the TCP group, 
however, cell amount increased similarly in OM, BMP-2, 
and BMP-7 medium (Figure 1). DNA amount was signifi-
cantly greater in the BAG group in CM at days 7 and 14 
(p < 0.001) and in OM at day 14 (p < 0.0001) as compared 
to the β-TCP group, suggesting a greater cell proliferation 
rate in response to BAG (Figure 1).
BMP-2- and BMP-7-supplemented media 
decrease cell amount regardless of 
biomaterial
For the BAG and β-TCP group individually, results of CM 
and TM were compared among each other to evaluate the 
effects of different media on cell amount. In the BAG 
group, when compared to the CM, significantly lower 
qDNA amounts were measured in BMP-2 medium at day 
7 as well as in BMP-7 and BMP-2/7 medium at days 7 and 
14 (p < 0.03), but significantly higher qDNA levels were 
measured in OM at day 14 (p < 0.01) (Figure 1). When 
compared to OM, cell amount was significantly lower in 
all BMP media at days 7 and 14 (p < 0.03) except for 
BMP-2 at day 7, suggesting a negative impact of BMP 
supplementation on cell amount in BAG (Figure 1). In the 
β-TCP group, when compared to CM, overall qDNA 
amounts were significantly higher in OM at days 7 and 14 
and in BMP-supplemented media at day 14 (p < 0.05) sug-
gesting enhanced cell proliferation. When compared to 
OM, cell amount was significantly lower in BMP-2 media 
at day 7 as well as in BMP-7 and BMP-2/7 at days 7 and 
14 (p < 0.03). Overall, BMP supplementation of TM 
resulted in reduced cell amounts as compared to OM inde-
pendent of biomaterial (Figure 1).
ALP activity in response to CM and OM is 
differently regulated in hASCs cultured with 
BAG and E-TCP
Qualitatively, osteogenic differentiation of hASCs was 
determined by ALP staining and quantitatively by ALP 
analyses. Results of BAG and β-TCP groups, when main-
tained in the same media, were compared to evaluate the 
effects of each biomaterial on osteogenic differentiation. 
Overall, our qALP measurements were consistent with the 
ALP staining results.
ALP staining indicated osteogenic differentiation of 
hASCs in BAG and β-TCP groups, but both biomaterials 
influenced this process differently. BAG exerted the most 
beneficial effect on differentiation when maintained in 
CM only (Figure 2), and ALP activity was decreased when 
OM was used. On the contrary, hASCs cultured with β-
TCP required OM for osteogenic differentiation (Figure 
2). Although BMP supplementation demonstrated no qual-
itative enhancing effect on osteogenic differentiation inde-
pendent of biomaterial, a significantly lower ALP activity 
was quantitatively measured in BAG group in BMP-2 and 
BMP-7 medium at day 14 (p < 0.05) when compared to 
β-TCP group (Figure 3). The superior osteogenic potential 
of BAG when maintained in plain CM was confirmed by 
significantly greater qALP activities at days 1, 7, and 14 (p 
< 0.001) (Figure 3).
Figure 2. Alkaline phosphatase (ALP) staining at day 14 (N = 5 replicates per group). BAG stimulated osteogenic differentiation in 
CM most, whereas E-TCP exerted the greatest effects in OM. An increase in color intensity correlates with increased ALP synthesis.
BAG: bioactive glass; CM: control medium; E-TCP: beta-tricalcium phosphate; OM: osteogenic medium; BMP: bone morphogenetic protein.
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Figure 3. Comparative overview on quantitative ALP measurements over time (N = 10 replicates per time point). Human ASCs 
responded to both biomaterials differently. Bioactive glass promoted greatest ALP gene expression in CM after 14 days whereas 
E-TCP provoked highest ALP expressions in OM. BMPs decreased ALP activities independent on biomaterial evaluated. Overall, the 
results were supported by ALP staining.
ALP: alkaline phosphatase; ASC: adipose stem cell; CM: control medium; OM: osteogenic medium; E-TCP: beta-tricalcium phosphate; BMP: bone 
morphogenetic protein; TM: treatment media.
The symbol ‘*’ indicates significant difference between days 1–7 and days 7–14; “a” indicates significant difference between days 1 and 14; “b”  
indicates significant difference when compared to CM; “c” significant different when compared to OM; arrows represent significant differences 
between biomaterials.
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BMP-2- and BMP-7-supplemented 
media decrease ALP activity regardless of 
biomaterial
Both biomaterials showed an initial reduction in qALP 
activity from days 1 to 7 that did not correspond with qDNA 
measurements, followed by an increase of qALP from days 
7 to 14 (Figures 1 and 3). We did not find statistically sig-
nificant correlation between cell amounts and qALP for 
either biomaterial. Specifically, in the BAG group, an ini-
tial decrease in qALP activity was measured on day 7 fol-
lowed by an increase on day 14 in all TMs. This initial 
activity decline was significant for OM, BMP-2/7 medium 
only (p < 0.03), whereas the subsequent rise from days 7 to 
14 was significant for CM and OM (p < 0.02). The overall 
increase from days 1 to 14 was significantly greater in CM 
and OM only (p < 0.04). When compared to CM, signifi-
cantly lower activities were measured at day 1 in OM and 
BMP-2 medium only, but for all TMs at days 7 and 14 (p < 
0.05), also suggesting an overall stimulatory effect of plain 
CM on early osteogenic differentiation in BAG group. 
When compared to OM, significantly lower qALP activi-
ties were measured in all BMP media at day 14 (p < 0.03), 
which was consistent with ALP staining and was sugges-
tive of an inhibitory effect of BMPs on osteogenic differen-
tiation (Figures 2 and 3). Similarly in the β-TCP group, an 
initial nonsignificant drop in qALP activity was measured 
on day 7 followed by a significant rise from days 7 to 14 in 
CM and all TMs (p < 0.01). The overall increase from days 
1 to 14 was significantly greater in OM, BMP-2, and 
BMP-7 medium (p < 0.05). When compared to the CM, 
expressions were significantly higher in OM and BMP-2 
medium at day 14 (p < 0.01), which was in alignment with 
our ALP staining for OM (Figures 2 and 3). When com-
pared to OM, significantly lower ALP expressions were 
measured in BMP-7 and BMP-2/7 medium at day 14 (p < 
0.02), suggesting an inhibitory effect of both BMPs in early 
osteogenic differentiation (Figure 3). Qualitatively, ALP 
staining was consistent with our qDNA measurements 
regarding the inhibitory effect of BMP supplementation to 
TM in both biomaterials.
BMP-2/7-supplemented media induces 
expression of OPN in hASCs cultured on 
BAG but not on E-TCP
To further analyze the influence of biomaterials and growth 
factors on osteogenic differentiation of hASCs, the expres-
sion of osteogenic marker genes OPN, RUNX-2, Col-1, 
and OC was measured at day 14.
In the BAG group, mRNA expression of OPN was sig-
nificantly higher in the BMP-2/7 medium as compared to 
CM, OM, and BMP-2 medium (p < 0.03) (Figure 4(a)), 
which was also in alignment with ALP activities recorded 
for BAG in CM and OM at day 14. Surprisingly, this effect 
was not seen in the β-TCP group, and mRNA expressions 
of OPN among TMs were not different. However, OPN 
gene expression in the BAG group was significantly 
stronger in BMP-2/7 medium (p < 0.01) as compared to the 
β-TCP group (Figure 4(a)).
In the BAG group and in alignment with the ALP activ-
ity, Col-1 expressions were significantly lower in TM as 
compared to CM (p < 0.01) (Figure 5(a)).
In the β-TCP group, mRNA expressions for Col-1 were 
not different among TMs, which was also confirmed by 
ALP activity measurements. However, Col-1 expressions 
were significantly lower in the BMP-7 and BMP-2/7 
medium when compared to CM (p < 0.009) (Figure 5(a)).
The mRNA expression for RUNX-2 was significantly 
lower in OM in the BAG group (p < 0.01) than in the β-TCP 
group (Figure 4(b)), which was in alignment with ALP 
staining (Figure 2). However, the expression was not regu-
lated by OM or growth factors when compared in the same 
biomaterial group. Similar expressions of OC were meas-
ured in BAG and β-TCP groups in CM and TM. When 
compared within biomaterial groups, the expression was 
neither different between CM and TM nor among TMs 
(Figure 5(b)).
VEGF expression correlated the cell 
amounts with both biomaterials
The effect of the biomaterial on the angiogenic potential of 
hASCs was determined by VEGF analyses. The expression 
of VEGF correlated with the cell amounts in both biomate-
rials. The Spearman correlation coefficient was 0.75 (p = 
0.0012) and 0.56 (p = 0.031) for BAG and β-TCP, 
respectively.
The results of BAG and β-TCP group were compared to 
evaluate the effects of each biomaterial when maintained in 
the same media. In the BAG group, VEGF expression was 
significantly lower in CM and TM as compared to β-TCP 
group except for CM at days 7 and 14 as well as in OM at 
day 14 (p < 0.04). This observation is suggestive for an 
overall positive effect of β-TCP in combination with BMPs 
on angiogenic potential when compared to BAG granules 
(Figure 6).
For each biomaterial individually, the results of CM 
and TM were compared to determine the influence of cul-
ture media on angiogenic potential of hASCs. In both bio-
material groups, VEGF levels rose continuously over time 
and reached highest levels after 14 days in CM and TM 
(Figure 6). In the BAG group, a continuously significant 
increase was observed from days 1 to 14 in CM and all 
TMs (p < 0.002). When compared to CM, VEGF levels 
were significantly lower in all TMs at all time points (p < 
0.04). When compared to OM, significantly reduced 
VEGF levels were measured in all BMP media at days 7 
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Figure 4. Comparative overview on gene expression of OPN and RUNX-2 (N = 6 replicates per time point). (a) OPN gene 
expression was significantly upregulated by BAG in BMP-2/7 medium as compared to E-TCP. Furthermore, BMP-2/7 induced 
significantly higher OPN expression as compared to BMP-2 in BAG group, suggesting a permissive effect on early osteogenesis. 
(b) RUNX-2 gene expression was significantly upregulated by E-TCP in OM as compared to BAG. However, additional BMP 
supplementation failed to enhance the expression. These findings were in alignment with ALP staining.
OPN: osteopontin; RUNX-2: runt-related transcription factor 2; BAG: bioactive glass; CM: control medium; OM: osteogenic medium; BMP: bone 
morphogenetic protein; E-TCP: beta-tricalcium phosphate; ALP: alkaline phosphatase; TM: treatment media.
The symbol “*” indicates significant difference between biomaterials; “a” indicates significant different as compared to CM; “b” indicates significant 
different as compared to OM.
and 14 (p < 0.04) (Figure 6). In the β-TCP group, the gradual 
increase of VEGF expression was significant in CM, OM, 
BMP-2, and BMP-7 media from days 1 to 7 (p < 0.0007), 
in all TMs from days 7 to 14 (p < 0.01) and in CM and all 
TMs from days 1 to 14 (p < 0.0005). When compared to 
CM, VEGF levels were significantly lower in all TMs at 
days 1 and 7 (p < 0.04). When compared to OM, signifi-
cantly decreased VEGF levels were measured in BMP-2 
medium at day 7 and in BMP-7 and BMP-2/7 at days 1 
and 7 (p < 0.03).
10 Journal of Tissue Engineering 3(1)
Discussion
To our knowledge, our study is the first report evaluating 
the effect of BAG and β-TCP on osteogenic differentiation 
of hASCs in HS-supplemented medium. The effects of CM, 
OM, and growth factor–supplemented (BMP-2, BMP-7, or 
BMP-2/7) OM on osteogenic differentiation of hASCs on 
BAG, and β-TCP granules were investigated concurrently.
In the current study, hASCs were used as a stem cell 
source for bone tissue engineering since they are readily 
Figure 5. Comparative overview on gene expression of Col-1 and OC (N = 6 replicates per time point). (a) Our data revealed 
significantly lower marker expression for Col-1 in all TMs in the BAG group as compared to CM and was in accordance with ALP 
stainings. However, E-TCP downregulated Col-1 expression in BMP-7 and BMP-2/7 media only as compared to CM. (b) The gene 
expression for OC was neither different between biomaterials nor among media evaluated.
Col-1: collagen type-1; OC: osteocalcin; CM: control medium; ALP: alkaline phosphatase; E-TCP: beta-tricalcium phosphate; OM: osteogenic medium; 
BMP: bone morphogenetic protein; TM: treatment media.
“a” indicates significant different as compared to CM.
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available and show similar osteogenic differentiation 
potential as compared to hBMSCs.18
In the past, FBS has been used for expansion and dif-
ferentiation of stem cells but recently, safety concerns have 
arisen regarding the use of this animal-derived product for 
clinical application in human medicine. Therefore, alterna-
tives including HS have been investigated.7,16 In theory, 
substitution of FBS by HS would overcome safety risks 
and, therefore, peaked interest in orthopedic research.19 
Recently, the supportive effect of pooled HS on 
Figure 6. Comparative overview on VEGF measurements over time (N = 6 replicates per time point). Overall, a superior effect of 
E-TCP on early angiogenic potential was detected in BMP-supplemented media as compared to BAG. Supplementation with BMPs 
decreased early angiogenic potential of BAG. However, BAG had an increased potential in CM as compared to E-TCP.
VEGF: vascular endothelial growth factor; E-TCP: beta-tricalcium phosphate; CM: control medium; OM: osteogenic medium; BMP: bone morphoge-
netic protein; TM: treatment media.
The symbol “*” indicates significant difference between days 1–7 and days 7–14; “a” indicates significant difference between days 1 and 14; “b” indi-
cates significant difference when compared to CM; “c” indicates significant difference when compared to OM; arrows represent significant differences 
between biomaterials.
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proliferation of hASCs was demonstrated,7 but the impact 
of HS on osteogenic differentiation when combined 
with biomaterials remained to be determined. Therefore, in 
the current study, hASCs cultured in HS-supplemented 
medium, and clinically used biomaterials and growth fac-
tors were investigated to meet current safety standards 
while mimicking a feasible clinical application.
The cell amounts were increasing over time with both 
biomaterials suggesting that HS-supplemented medium in 
combinations with BAG and β-TCP can provide sufficient 
amounts of attachment factors for hASCs. The positive 
effect of BAG and β-TCP on MSC proliferation has been 
reported previously.13,20–22 Our results were in accordance 
with these studies; however, BAG appeared to have a supe-
rior effect on hASC mount as compared to β-TCP when 
maintained in CM and OM. The surface roughness and 
porosity differ between BAG and β-TCP materials used in 
our study. However, the obtained DNA amount was similar 
with both biomaterials on day 1 in all groups, suggesting 
similar amounts of attached cells at the beginning of the 
experiments.
The effect of BAG and β-TCP on osteogenic differentia-
tion of hBMSCs and hASCs has been previously stud-
ied.20,23,24 Similarly to these reports, both biomaterials 
supported osteogenic differentiation in the current study as 
indicated by ALP activity. The most enhancing effect of 
BAG on differentiation was measured in CM, whereas the 
use of OM decreased ALP activity. In contrast to BAG, 
osteogenic induction of hASCs was greatest in OM when 
cultured with β-TCP.
Interestingly but consistent for both biomaterials inde-
pendent on culture medium, a discrepancy between cell 
proliferation and osteogenic differentiation was noticed at 
day 7. Although cells steadily proliferated, concurrent oste-
ogenic differentiation was not observed within the first 
seven days as indicated by decreasing qALP activities. This 
was in contrast with a previous report, in which ALP activ-
ity increased consistently over 14 days followed by a 
decrease after 21 days and requires further investigation.20
Currently, BMP-2 and BMP-7 are in clinical use since 
their osteoinductive effect has been demonstrated in vari-
ous studies.10,11 Due to their clinical approval, their poten-
tial use for other applications in human medicine is 
appealing and has resulted in further research.
In our current study, BMP supplementation decreased 
cell amounts regardless of the used biomaterial. In contrast 
to our findings, the beneficial effects of BMP-2 and BMP-7 
on proliferation of hBMSCs have been demonstrated.25 
However, consistent with our findings, the negative impact 
of BMP-2 on cell growth rates was recently demonstrated 
in primary immortalized human fetal and primary human 
osteoblasts.26 Additionally, higher apoptosis rates were 
recorded after exposure to BMP-2 and BMP-7.26 These 
observations may suggest decreased cell growth via apop-
tosis after BMP supplementation but remains to be 
determined.
Although the supportive effect of BMP-2 and BMP-7 on 
the osteogenic differentiation of MSC has been well docu-
mented in vivo,27,28 conflicting results have been obtained 
in vitro. Our in vitro findings were suggestive for a nega-
tive impact of both growth factors on osteogenic differen-
tiation of hASCs. Over time, decrease in ALP activities was 
observed in BMP-supplemented OM independent on bio-
material evaluated. Recently,17 it was suggested that the 
canonical BMP-2 signaling pathway may not be functional 
in hASCs, and thus, their osteogenic differentiation may 
not be influenced by BMP-2 even in vivo.29 However, 
those results were in contrast with a recent study, in which 
rat bone marrow stromal cells (BMSCs) differentiated in 
the presence of BMP-2 and BAG into more rounded osteo-
blast-like cells resulting in greater ALP expression.28 
Similarly, when β-TCP containing collagen sponges were 
used as carrier for rat BMSCs and BMP-2, an enhanced 
osteogenic differentiation was confirmed by increased ALP 
and OC gene expression and histology.27
The negative effect on differentiation may also origi-
nate in the autoregulatory negative feedback loop of BMP 
preventing excessive stimulation. BMPs exert their effects 
via receptors that activate Smad-dependent and Smad-
independent mechanisms resulting in linear expression of 
target genes including early markers of osteogenesis such 
as OC, ALP, or Col-1.30 Several factors may be involved in 
this negative feedback loop including negative nonsignal-
ing pseudoreceptors (BAMBI), inhibitory Smads (Smad 6 
or 7), Smad-binding proteins (Ski and Tob), or degradation 
of Smads and extracellular BMP antagonists.31 Among 
those, continuous exposure to BMP may have resulted in 
Smad 6 or 7 and/or Ski accumulation operating the nega-
tive feedback loop. This assumption is supported by a 
recent study in which no BMP-induced nuclear transloca-
tion of Smad 1/Smad 4 complexes was observed, suggest-
ing a nonfunctional BMP-2 signaling pathway in hASCs.17 
However, a consistent downregulation of all osteogenic 
markers should have been observed. The exact timing after 
BMP stimulation of each individual marker remains to be 
determined.
The discrepancy between our results and previous 
observations may also originate in the BMP delivery 
method. In general, growth factors can be delivered exog-
enously via frequent media changes or endogenously via 
gene therapy. The effect of BMP-2 and BMP-7 on hASCs 
was investigated using frequent medium changes in the 
current study. The osteogenic differentiation of BMP-2 
transfected rat BMSCs cultured with β-TCP scaffolds were 
recently investigated in vivo. Contrary to our findings, 
mRNA expression of OPN and OC was significantly 
increased, and ALP staining was more intensive.21 In 
another study, MSCs were co-transfected with BMP genes, 
resulting in endogenous BMP synthesis. A prolonged effect 
for weeks was achieved after transfection.32 These data 
may suggest that gene therapy is a more efficient method in 
supporting osteogenic differentiation of MSCs than regular 
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media changes. Those contradictory results highlight the 
importance of delivery systems for BMPs and call for addi-
tional investigations. Interestingly, in our study, OPN was 
the only marker of which expression was increased by 
BMPs but this was only detected in BAG and requires fur-
ther investigations.
Formation of vasculature is essential for bone forma-
tion. In the current study, VEGF was measured since its 
validity as early marker for angiogenic potential is well 
documented and the VEGF secretion is considered as a 
permissive factor for bone formation.33 In our study, both 
biomaterials consistently supported VEGF expression in 
all samples. This is in accordance with recent studies, in 
which the beneficial effects of BAG and β-TCP on VEGF 
secretion were reported.34,35 Our results suggest a signifi-
cantly better effect of β-TCP on the VEGF secretion of 
hASCs in BMP-supplemented OM when compared to 
BAG at all times. These findings are supported by a previ-
ous study, in which the efficacy of MSCs seeded on β-TCP 
scaffolds was investigated in rats.36 An upregulation of 
VEGF mRNA and protein levels was measured over time, 
which also resulted in greater bone formation in vivo. 
Potentially, β-TCP granules in BMP-2- and BMP-7-
supplemented OM may support the angiogenic potential of 
hASCs, whereas BAG under similar culture conditions 
may even decrease the VEGF expression but this requires 
further clarification.
Although the positive effects of both BMPs on angio-
genesis have been well reported using different cell lines, 
media, and biomaterials,37 this is the first in vitro study 
investigating the VEGF secretion of hASCs when exposed 
to BAG or β-TCP and supplemented with BMPs. Contrary 
to those well-known supportive effects, BMP-2 and BMP-7 
supplementation of BAG decreased the angiogenic poten-
tial of hASCs in our study.
The VEGF secretion solely followed the pattern of cell 
amount. Interestingly, a recent study demonstrated an 
inhibitory effect of BMPs on cell proliferation and angio-
genesis. Recently, the negative effect of BMP-2 on oral 
squamous cell carcinoma proliferation and angiogenesis 
was demonstrated.38 Also, the interaction of VEGF and 
BMP-2 was investigated in BMSC in vitro and in vivo. 
Those coculture experiments revealed VEGF as a potent 
inhibitor of BMP-2 expression and, thus, may inhibit 
osteogenesis.39 Similarly, in our study, inhibition of early 
osteogenesis may have been indicated by reduced qALP 
activity secondary to VEGF expression. These findings call 
for studies elucidating the exact role of BMP-2, BMP-7, 
and VEGF on the angiogenic and osteogenic potentials of 
hASCs.
In conclusion, hASCs can be successfully isolated and 
expanded in HS but the response differs on BAG S53P4 
and β-TCP granules. In the current study, BAG S53P4 stim-
ulated osteogenic differentiation of hASCs in CM, whereas 
β-TCP required OM for osteogenic induction. Overall, 
supplementation of OM with BMP-2 and BMP-7 decreased 
early osteogenic differentiation independent on biomaterial 
evaluated. Based on our measurements, a combination of 
BAG S53P4 and CM may be an applicable way in enhanc-
ing proliferation and osteogenic differentiation of hASCs 
while minimizing safety and regulatory concerns in bone 
tissue engineering. Further studies elucidating the individ-
ual role of growth factors and biomaterials are required to 
design an effective bone tissue engineered implant suitable 
for clinical use. This study is a preliminary step forward in 
achieving this goal.
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